Prior to joining the Life Sciences Institute, Dr. Getman was Vice President, Pfizer Global Research and Development and Director, St. Louis Laboratories, where he built an effective site leadership team and established Pfizer's St. Louis Laboratories as a critical component of the global research organization focused on three strategically important areas; biotherapeutics, inflammation research and indications discovery. Prior to his role with Pfizer, he worked with Pharmacia, Searle and Monsanto in St Louis.
While with Pharmacia, Dr. Getman served as Sr. Director and Co-Chair of the Exploratory Development Committee where he was responsible for the early human clinical portfolio spanning five research sites worldwide. He and his team mentored project teams to select drug candidates, effectively transition them into human clinical trials and complete human Phase II proof-of-concept studies. One of those teams brought forward Sutent® for renal and gastrointestinal cancer.
Prior to that Dr. Getman held a variety of positions with Monsanto/Searle including Sr. Director, Medicinal Chemistry and a member of the Discovery Leadership Team. His research experience spans synthetic and medicinal chemistry in the areas of arthritis, cancer and infectious diseases, including AIDS. Dr. Getman led several large discovery projects including the HIV protease project that led to three separate licensing deals and two marketed products for AIDS patients. He is an inventor on over 50 patents and author or co-author on over 25 publications.
Dr. Getman is an active member of a number of key life sciences organizations in the Kansas, Missouri and the Kansas City region.
Dr. Getman received a Ph.D. in Organic Chemistry from the University of Minnesota in Minneapolis in 1982, and a B.S. in Chemistry from the State University of New York at Buffalo in 1977.